Physician Assistant in South Lyon, MI Accepting Medicare
6 Physician Assistant nurses found. Showing 1 - 6
 Randall Stein, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 210 N. Lafayette, South Lyon, MI 48178 Phone: 248-437-1744 Fax: 248-446-2420 |
 Jenna Marie Carter, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 22024 Pontiac Trl, South Lyon, MI 48178 Phone: 248-437-2525 |
Vincent Robert Gasparotto, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 22990 Pontiac Trl, South Lyon, MI 48178 Phone: 248-667-9202 |
Morgan A Covington, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 26006 Pontiac Trl, South Lyon, MI 48178 Phone: 248-437-5613 Fax: 248-437-5694 |
Alexandrea T Bedirian, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 26036 Pontiac Trl, South Lyon, MI 48178 Phone: 248-479-2200 |
Mrs. Rachael Lynn Blea, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 12660 Ten Mile Rd, South Lyon, MI 48178 Phone: 248-348-1131 Fax: 248-348-1171 |
News Archive
Bionovo completes 13 weeks repeat dose animal toxicology studies for Menerba
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today the successful completion of 13 weeks repeat dose animal toxicology studies with Menerba.
Longer looks: Manufacturing killer flu; The ironies of the individual mandate; When the elderly refuse help
In experiments conducted at the University of Wisconsin in Madison and Erasmus University in Rotterdam, the Netherlands, researchers engineered a strain of H5N1. … The next logical step would be for the researchers to publish studies in major scientific journals, describing the newly created flu, including its genetic makeup.
Adding berzosertib to standard treatment for metastatic urothelial cancer does not extend patient survival
A Phase 2 trial led by City of Hope, a world-renowned research and treatment center for cancer and diabetes, suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care chemotherapy for patients with metastatic urothelial cancer does not extend progression-free survival.
Addition of inflammatory biomarkers to clinical variables improve mortality prediction in COPD
The addition of changes in inflammatory biomarkers to established clinical variables improves the prediction of mortality in patients with chronic obstructive pulmonary disease (COPD), according to a new study.
New DNA study reveals settlement history of early Eskimos
Genetic testing of Iñupiat people currently living in Alaska's North Slope is helping Northwestern University scientists fill in the blanks on questions about the migration patterns and ancestral pool of the people who populated the North American Arctic over the last 5,000 years.
› Verified 6 days ago